glp-1 drug news Poll: 1 in 8 Adults Say They Are Currently Taking a for Weight Loss, Diabetes or Another Condition, Even as Half Say the Drugs Are Difficult to Afford GLP-1 Medications for Weight Loss:

A recent study tracked self-reported GLP-1 side effects among Reddit users and found several overlooked side effects like chills and hot flashes linked to weight loss medications like Ozempic and Mounjaro.

Two major ongoing trials are likely to change that, with potentially big implications for clinical practice.

Here, the authors review the physiological roles of GLP-1, the potential renoprotective mechanisms of incretin-based therapies and the available renal outcome data from clinical trials.

Partly through these actions, GLP-1 receptor agonism was shown to reduce cardiovascular disease (CVD) in people with T2D with previous CVD or at high-risk thereof